Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rhTPO for Chemotherapy-Induced Thrombocytopenia
NCT03633019Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Sep 2018
- Primary completion
- Nov 2019
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT03633019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633019.